Prof Tim Anderson
BSc(Hons), MBChB, MD, FRACP
Clinical Director
New Zealand Brain Research Institute, Christchurch
Professor
Department of Medicine, University of Otago, Christchurch
I am a Neurologist, with subspecialty expertise in Movement Disorders including Parkinson’s, Huntington’s disease and botulinum toxin therapy.
I undertake two specialty clinics in movement disorders per week and fortnightly botulinum toxin clinics for the CDHB. I teach 5th year University of Otago, Christchurch medical students including hosting students at my outpatient clinics
My research interests and expertise are
- establishing biomarkers of cognitive decline to mild cognitive impairment (MCI) and dementia, particularly advanced MRI markers in Parkinson’s disease but also other dementias;
- eye movements in PD and other neurological disorders, in collaboration with Dr M MacAskill,
- clinical biomarkers of progression in Huntington’s disease, and
- speech and swallowing disorders in health and neurological disorders.
I regularly conduct clinical pharmaceutical trials in Parkinson’s and other neurological disorders This has enabled patients not only to have early access to new treatments but also and regular clinical review and oversight. My passions are golf, tennis and sailing and as often as possible I escape to our wee holiday house at Akaroa, a harbour village one hour’s drive from Christchurch
Publications
Provided on request for non-commercial personal use by researchers.
2024
Aye, W. W., Stark, M. R., Horne, K.-L., Livingston, L., Grenfell, S., Myall, D. J., Pitcher, T.L., Almuqbel, M.M., Keenan, R. J., Meissner, W.G., Dalrymple-Alford, J., Anderson, T.J., Le Heron, C., Melzer, T. R. (2024). Early‐phase amyloid PET reproduces metabolic signatures of cognitive decline in Parkinson's disease. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 16(2),
e12601..
10.1002/dad2.12601
Bernhardt, I., Frajman, L. E., Ryder, B., Andersen, E., Wilson, C., McKeown, C., ..., Anderson, T.J., ..., Glamuzina, E. (2024). Further delineation of short chain enoyl CoA hydratase deficiency in the Pacific population. Molecular Genetics and Metabolism, .
10.1016/j.ymgme.2024.108508
Gooch, E., Melzer, T.R., Horne, K.L., Grenfell, S., Livingston, L., Pitcher, T., Dalrymple-Alford, J.C., Anderson, T.J., McAuliffe, M.J., Theys, C. (2024). Higher Frequency of Stuttered Disfluencies Negatively Affects Communicative Participation in Parkinson's Disease. Journal of Speech Language and Hearing Research, .
10.1044/2024_JSLHR-24-00018
Kennedy, E., Liebel, S.W., Lindsey, H.M, ..., Anderson, T.J, ..., Dalrymple-Alford, J.C, ..., Melzer, T.R., ..., Myall, D.J, ..., Dennis, E.L. (2024). Verbal Learning and Memory Deficits across Neurological and Neuropsychiatric Disorders: Insights from an ENIGMA Mega Analysis. Brain Sciences,
14(7), .
10.3390/brainsci14070669
Kim, J. J., Vitale, D., Otani, D. V., Lian, M. M., Heilbron, K., Iwaki, H., ..., the Global Parkinson’s Genetics Program (GP2), ..., Mata, I. (2024). Multi-ancestry genome-wide association meta-analysis of Parkinson’s disease. Nature genetics,
56, .
10.1038/s41588-023-01584-8
Le Heron, C., Horne, K. L., MacAskill, M. R., Livingston, L., Melzer, T. R., Myall, D., Pitcher, T., Dalrymple-Alford, J., Anderson, T., Harrison, S. (2024). Cross-Sectional and Longitudinal Association of Clinical and Neurocognitive Factors With Apathy in Patients With Parkinson Disease. Neurology,
102(12), .
10.1212/WNL.0000000000209301
Morris, L. A., Horne, K. L., Manohar, S., Paermentier, L., Buchanan, C., MacAskill, M., Myall, D., Apps, M., Roxburgh, R., Anderson, T., Husain, M., Le Heron, C. (2024). Decision cost hypersensitivity underlies Huntington’s disease apathy. Brain,
awae296.
10.1093/brain/awae296
Morris, L.-A., Horne, K.-L., Paermentier, L., Buchanan, C.M., MacAskill, M., Myall, D., Husain, M., Roxburgh, R., Anderson, T. and Heron, C.L. (2024). Apathy and Impulsivity Co-Occur in Huntington's Disease. Brain and Behavior,
14: e70061..
10.1002/brb3.70061
Owens-Walton, C., Nir, T. M., Al-Bachari, S., Ambrogi, S., Anderson, T. J., Aventurato, I. K., ..., Dalrymple-Alford, J.C, ..., Melzer, T.R, ..., Pitcher, T.L., ..., van der Werf, Y. D. (2024). A Worldwide Study of White Matter Microstructural Alterations in People Living with Parkinson's Disease. medRxiv, .
10.1101/2024.01.16.24301235
Slater, N., Melzer, T.R., Myall, D.J., Anderson, T.J., Dalrymple-Alford, J.C. (2024). Cholinergic basal forebrain integrity and cognition in Parkinson’s disease: a re-appraisal of MRI evidence. Movement Disorders,
12, .
10.1002/mds.30023
2023
Anderson, T.J. (2023). Eyelid nystagmus and other involuntary movements of the upper lids; what's in a name? Movement Disordors Clinical Practice.
10.1002/mdc3.13805
Blommer, J., Pitcher, T., Mustapic, M., Eren, E., Yao, P. J., Vreones, M. P., Pucha, K. A., Dalrymple-Alford, J., Shoorangiz, R., Meissner, W. G., Anderson, T., Kapogiannis, D. (2023). Extracellular vesicle biomarkers for cognitive impairment in Parkinson’s disease. Brain,
146(1), .
10.1093/brain/awac258
Dalrymple-Alford, J.C., Anderson, T.J., Melzer, T.R. (2023). Thalamus, thalamocortical networks, and non-motor symptoms in Parkinson’s disease. book chapter in Cerebral Cortex and Thalamus XII.
Gooch, E. A., Horne, K.-L., Melzer, T. R., McAuliffe, M. J., MacAskill, M., Dalrymple‐Alford, J. C., Anderson, T.J., Theys, C. (2023). Acquired Stuttering in Parkinson's Disease. Movement Disorders Clinical Practice.
10.1002/mdc3.13758
Guan, J., Li, F., Kang, D., Anderson, T., Pitcher, T., Dalrymple-Alford, J., Shorten, P., Singh-Mallah, G. (2023). Cyclic Glycine-Proline (cGP) Normalises Insulin-Like Growth Factor-1 (IGF-1) Function: Clinical Significance in the Ageing Brain and in Age-Related Neurological Conditions. Molecules,
28, .
10.3390/molecules28031021
Kennedy, E., Vadlamani, S., Lindsey, H. M., Lei, P. W., Pugh, M. J., Adamson, M., ... , Anderson, T.J., ... , Dalrymple-Alford, J.C., ... , Melzer, T.R, ... , Myall, D.J., ... , Wilde, E. A. (2023). Bridging Big Data: Procedures for Combining Non-equivalent Cognitive Measures from the ENIGMA Consortium. bioRxiv, .
10.1101/2023.01.16.524331
Kerestes, R., Laansma, M., ..., Anderson, T., ..., Dalrymple-Alford, J., ..., Melzer, T., ..., Pitcher, T., ..., the ENIGMA-Parkinson's Study (2023). Cerebellar Volume and Disease Staging in Parkinson's Disease: An ENIGMA-PD Study. Movement Disorders.
10.1002/mds.29611
MacAskill, M. R., Pitcher, T. L., Melzer, T. R., Myall, D. J., Horne, K.-L., Shoorangiz, R., Almuqbel, M. M., Livingston, L., Grenfell, S., Pascoe, M. J., Marshall, E. T., Marsh, S., Perry, S. E., Meissner, W. G., Theys, C., Le Heron, C. J., Keenan, R. J., Dalrymple-Alford, J. C., Anderson, T. J. (2023). The New Zealand Parkinson’s Progression Programme. Journal of the Royal Society of New Zealand,
53, .
10.1080/03036758.2022.2111448
Morris, L. A., Harrison, S. J., Melzer, T. R., Dalrymple-Alford, J. C., Anderson, T. J., MacAskill, M. R., Le Heron, C. J. (2023). Altered nucleus accumbens functional connectivity precedes apathy in Parkinson’s disease. Brain,
awad113.
10.1093/brain/awad113
Thompson, N., MacAskill, M., Pascoe, M., Anderson, T., Heron, C. L. (2023). Dimensions of apathy in Parkinson’s disease. Brain and Behaviour,
e2862, .
10.1002/brb3.2862
2022
Boel, J. A., Bie, R. M. A., Schmand, B. A., Dalrymple‐Alford, J. C., Marras, C., Adler, C. H., Goldman, J. G., Tröster, A. I., Burn, D. J., Litvan, I., Geurtsen, G. J., the MDS Study Group Mild Cognitive Impairment in Parkinson’s Disease (2022). Level I PD‐MCI using global cognitive tests and the risk for Parkinson’s disease dementia. Movement Disorders Clinical Practice,
9(4), .
10.1002/mdc3.13451
Bronstein, A. M., Anderson, T. J., Kaski, D., MacAskill, M. R., Shaikh, A. (2022). Oculomotor and visuo-vestibular function in Parkinson’s disease. In N. Gálvez-Jiménez, A. D. Korczyn, & R. Lugo-Sanchez (Eds). Non-Motor Parkinson’s Disease,
Cambridge University Press.
Kassavetis, P., Kaski, D., Anderson, T. J., Hallett, M. (2022). Eye movement disorders in movement disorders. Movement Disorders Clinical Practice,
9(3), .
10.1002/mdc3.13413
Khwaounjoo, P., Singh, G., Grenfell, S., Özsoy, B., MacAskill, M. R., Anderson, T. J., Çakmak, Y. O. (2022). Non-contact hand movement analysis for optimal configuration of smart sensors to capture Parkinson’s disease hand tremor. Sensors,
22, .
10.3390/s22124613
Morgan, C.A., Roberts, R.P., Chaffey, T., Tahara-Eckl, L., van der Meer, M., Günther, M., Anderson, T.J., Cutfield, N.J., Dalrymple-Alford, J.C., Kirk, I.J., Addis, D R., Tippett, L.J., Melzer, T.R. (2022). Reproducibility and repeatability of magnetic resonance imaging in dementia. Physica Medica,
101, .
doi.org/10.1016/j.ejmp.2022.06.012
O'Brien, T.J., Berkovic, S.F., French, J.A., Messenheimer, J.A., Sebree, T.B, Bonn-Miller, M.O., Gutterman, D.L., for the STAR 1/STAR 2 Study Group. (2022). Adjunctive transdermal cannabidiol for adults with focal epilepsy:a randomized clinical trial. JAMA Network Open,
2022, .
10.1001/jamanetworkopen.2022.20189
Tippett, L. J., Cawston, E. E., Morgan, C. A., Melzer, T. R., Brickell, K. L., Ilse, C., Cheung, G., Kirk, I. J., Roberts, R. P., Govender, J., Griner, L., Le Heron, C., Buchanan, S., Port, W., Dudley, M., Anderson, T. J., Williams, J. M., Cutfield, N. J., Dalrymple-Alford, J. C., … the NZ-DPRC. (2022). Dementia Prevention Research Clinic: A longitudinal study investigating factors influencing the development of Alzheimer’s disease in Aotearoa. Journal of the Royal Society of New Zealand.
10.1080/03036758.2022.2098780
Zhao, Y., Laansma, M. A., van Heese, E. M., Owens-Walton, C., Parkes, L. M., Debove, I., Rummel, C., Wiest, R., Cendes, F., Guimaraes, R., Yasuda, C. L., Wang, J.-J., Anderson, T. J., Dalrymple-Alford, J. C., Melzer, T. R., Pitcher, T. L., Schmidt, R., Schwingenschuh, P., Garraux, G., … for the ENIGMA consortium. (2022). Learning interpretable regularized ordinal models from 3D mesh data for neurodegenerative disease staging. In Abdulkadir, Bathula, Dvornek, Habes, Kia, Kumar, & Wolfers (Eds.),. Machine Learning in Clinical Neuroimaging,
13596, .
10.1007/978-3-031-17899-3_12
2021
Basukala, D., Mukundan, R., Lim, A., Hurrell, M. A., Keenan, R. J., Dalrymple-Alford, J. C., Anderson, T. J., Myall, D. J., Melzer, T. R. (2021). Automated segmentation of substantia nigra and red nucleus using quantitative susceptibility mapping images: application to Parkinson’s disease. Computers & Electrical Engineering,
91, .
10.1016/j.compeleceng.2021.107091
Blakemore, R. L., Pascoe, M. J., Horne, K. L., Livingston, L., Young, B. N., Elias, B., Goulden, M., Grenfell, S., Myall, D. J., Pitcher, T. L., Dalrymple-Alford, J. C., Le Heron, C. J., Anderson, T. J., MacAskill, M. R. (2021). Higher perceived stress and exacerbated motor symptoms in Parkinson's disease during the COVID-19 lockdown in New Zealand. The New Zealand Medical Journal,
134, .
Horne, K., MacAskill, M. R., Myall, D. J., Livingston, L., Grenfell, S., Pascoe, M. J., Young, B., Shoorangiz, R., Melzer, T. R., Pitcher, T. L., Anderson, T. J., Dalrymple‐Alford, J. C. (2021). Neuropsychiatric symptoms are associated with dementia in Parkinson’s disease but not predictive of it. Movement Disorders Clinical Practice,
8, .
10.1002/mdc3.13151
Laansma, M. A., Bright, J. K., Al‐Bachari, S., Anderson, T. J., Ard, T., Assogna, F., Baquero, K. A., Berendse, H. W., Blair, J., Cendes, F., Dalrymple‐Alford, J. C., Bie, R. M. A., Debove, I., Dirkx, M. F., Druzgal, J., Emsley, H. C. A., Garraux, G., Guimarães, R. P., Gutman, B. A., Helmich, R. C., Klein, J. C., Mackay, C. E., McMillan, C. T., Melzer, T. R., Parkes, L. M., Piras, F., Pitcher, T. L., Poston, K. L., Rango, M., Ribeiro, L. F., Rocha, C. S., Rummel, C., Santos, L. S. R., Schmidt, R., Schwingenschuh, P., Spalletta, G., Squarcina, L., Heuvel, O. A., Vriend, C., Wang, J., Weintraub, D., Wiest, R., Yasuda, C. L., Jahanshad, N., Thompson, P. M., Werf, Y. D., The ENIGMA‐Parkinson’s Study. (2021). International multicenter analysis of brain structure across clinical stages of Parkinson’s disease. Movement Disorders ,
36, .
10.1002/mds.28706
Le Heron, C., MacAskill, M.R., Mason, D., Dalrymple-Alford, J., Anderson, T.J., Pitcher, T., Myall, D.J. (2021). A multi-step model of Parkinson’s disease pathogenesis. Movement Disorders,
36, .
10.1002/mds.28719
Le Heron, C., Myall, D., Anderson, T. (2021). Progression in Parkinson’s disease: a potpourri of plots and probabilities. Brain,
3, .
10.1093/brain/awab060
Morgan, C. A., Melzer, T. R., Roberts, R. P., Wiebels, K., Mutsaerts, H. J. M. M., Spriggs, M. J., Dalrymple-Alford, J. C., Anderson, T. J., Cutfield, N. J., Deib, G., Pfeuffer, J., Addis, D. R., Kirk, I. J., Tippett, L. J. (2021). Spatial variation of perfusion MRI reflects cognitive decline in mild cognitive impairment and early dementia. Scientific Reports,
11(1), .
10.1038/s41598-021-02313-z
Nabais, M. F., Laws, S. M., Lin, T., Vallerga, C. L., ..., Anderson, T. J., Bentley, S. R., Dalrymple-Alford, J., Fowder, J., Gratten, J., Halliday, G., Hickie, I. B., Kennedy, M., Lewis, S. J. G., Montgomery, G. W., Pearson, J., Pitcher, T. L., Silburn, P., Zhang, F., Visscher, P. M., Yang, J., Stevenson, A. J., Hillary, R. F., Marioni, R. E., Harris, S. E., Deary, I. J., Jones, A. R., Shatunov, A., Iacoangeli, A., van Rheenen, W., van den Berg, L. H., Shaw, P. J., Shaw, C. E., Morrison, K. E., Al-Chalabi, A., Veldink, J. H., Hannon, E., Mill, J., Wray, N. R., McRae, A. F. (2021). Meta-analysis of genome-wide DNA methylation identifies shared associations across neurodegenerative disorders. Genome Biology,
22, .
10.1186/s13059-021-02275-5
Wilson, D., Hallett, M., Anderson, T. (2021). An eye on movement disorders. Movement Disorders Clinical Practice,
8, .
10.1002/mdc3.13317
2020
Alamri, Y., Dalrymple-Alford, J., MacAskill, M. R., Anderson, T. J. (2020). Exploring eye movements of Parkinson’s disease patients performing the Judgement of Line Orientation test. Journal of Clinical Neuroscience,
76, .
10.1016/j.jocn.2020.04.031
Alamri, Y., Pitcher, T. L., Anderson, T. J. (2020). Variations in the patterns of prevalence and therapy in Australasian Parkinson’s disease patients of different ethnicities. BMJ Neurology Open,
2(1), .
10.1136/bmjno-2019-000033
Beecroft, S. J., Cortese, A., Sullivan, R., Yau, W. Y., Dyer, Z., Wu, T. Y., Mulroy, E., Pelosi, L., Rodrigues, M., Taylor, R., Mossman, S., Leadbetter, R., Cleland, J., Anderson, T., Ravenscroft, G., Laing, N. G., Houlden, H., Reilly, M. M., Roxburgh, R. H. (2020). A Māori specific RFC1 pathogenic repeat configuration in CANVAS, likely due to a founder allele. Brain,
awaa203. .
10.1093/brain/awaa203
Borlase, N., Myall, D., Melzer, T., Livingston, L., Watts, R., Keenan, R., MacAskill, M., Anderson, T., Dalrymple-Alford, J. (2020). Microstructural integrity of the major nuclei of the thalamus in Parkinson’s disease. bioRxiv, .
10.1101/2020.05.21.109660
Fan, D., Pitcher, T. L., Dalrymple-Alford, J., MacAskill, M. R., Anderson, T. J., Guan, J. (2020). Changes of plasma cGP/IGF‐1 molar ratio with age is associated with cognitive status of Parkinson disease. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring,
12, .
10.1002/dad2.12025
Graham, O. E., Pitcher, T. L., Liau, Y., Miller, A. L., Dalrymple-Alford, J. C., Anderson, T. J., Kennedy, M. A. (2020). Nanopore sequencing of the glucocerebrosidase (GBA) gene in a New Zealand Parkinson's disease cohort. Parkinsonism & Related Disorders,
70, .
10.1016/j.parkreldis.2019.11.022
Grasby, K. L. & Jahanshad, N. et al. (2020). The genetic architecture of the human cerebral cortex. Science,
367(6484), .
10.1126/science.aay6690
MacAskill, M. R., Myall, D. J., Pitcher, T.L., Anderson, T.J. (2020). “Pervasive ocular tremor of Parkinson’s” is not pervasive, ocular, or uniquely parkinsonian. OSFPreprints.
10.31219/osf.io/s8rwt
MacAskill, M. R., Myall, D. J., Shoorangiz, R., Anderson, T. J., Pitcher, T. L. (2020). Childbirth and delayed Parkinson’s onset: a reproducible non-biological artefact of societal change. Movement Disorders,
35, .
10.1002/mds.28135
Myall, D.J., Horne, K., MacAskill, M.R., Livingston, L., Pitcher, T.L., Melzer, T.R., Geurtsen, G.J., Anderson, T.J., Dalrymple-Alford, J.C. (2020). Cognitive tests that identify high risk of conversion to dementia in Parkinson's disease. bioRxiv, .
10.1101/2020.05.31.126870
Schierding, W., Farrow, S., Fadason, T., Graham, O. E. E., Pitcher, T. L., Qubisi, S., Davidson, A. J., Perry, J. K., Anderson, T. J., Kennedy, M. A., Cooper, A., O’Sullivan, J. M. (2020). Common variants coregulate expression of GBA and modifier genes to delay Parkinson’s disease onset. Movement Disorders, .
10.1002/mds.28144
Snell, D. L., Martin, R., Surgenor, L. J., Siegert, R. J., Hay-Smith, E. J. C., Melzer, T. R., Anderson, T. J., Hooper, G. J. (2020). Wrestling with uncertainty after mild traumatic brain injury: a mixed methods study. Disability and Rehabilitation,
42, 1942-1953.
10.1080/09638288.2018.1542461
Spencer, E. S., Pitcher, T., Veron, G., Hannam, T., MacAskill, M., Anderson, T., Dalrymple-Alford, J. C., Carr, A. C. (2020). Positive association of ascorbate and inverse association of urate with cognitive function in people with Parkinson’s disease. Antioxidants,
9, .
10.3390/antiox9100906
Vallerga, C., Zhang, F., Fowdar, J., McRae, A., Qi, T., Nabais, M., Zhang, Q., Kassam, I., Henders, A., Wallace, L., Montgomery, G., Chuang, Y-H., Horvath, S., Ritz, B., Halliday, G., Hickie, I., Kwok, J., Pearson, J., Pitcher, T., Kennedy, M., Bentley, S., Silburn, P., Yang, J., Wray, N., Lewis, S., Anderson, T., Dalrymple-Alford, J., Mellick, G., Visscher, P., Gratten, J. (2020). Analysis of DNA methylation associates the cystine-glutamate antiporter SLC7A11 with risk of Parkinson’s disease. Nature Communications ,
11 (1238), .
10.1038/s41467-020-15065-7
Wright, D., Rowley, R., Halks‐Wellstead, P., Anderson, T., Wu, T. Y. (2020). Abnormal saccadic oscillations associated with SARS‐CoV‐2 encephalopathy and ataxia. Movement Disorders Clinical Practice,
7, .
10.1002/mdc3.13101
d’Arbeloff, T., Elliott, M. L., Knodt, A. R., Melzer, T. R., Keenan, R., Ireland, D., Ramrakha, S., Poulton, R., Anderson, T.J., Caspi, A., Moffitt, T. E., Hariri, A. R. (2020). White matter hyperintensities are common in midlife and already associated with cognitive decline. Brain Communications,
1(1), .
10.1093/braincomms/fcz041
2019
Blakemore, R. L., MacAskill, M. R., Myall, D. J., Anderson, T. J. (2019). Volitional suppression of parkinsonian resting tremor. Movement Disorders Clinical Practice,
6, .
10.1002/mdc3.12801
Blauwendraat, C., Heilbron, K., Vallerga, C. L., Bandres‐Ciga, S., von Coelln, R., Pihlstrøm, L., Siitonen, A., International Parkinson's Disease Genomics Consortium (2019). Parkinson’s disease age at onset genome‐wide association study: Defining heritability, genetic loci, and α‐synuclein mechanisms. Movement Disorders,
34(6), .
10.1002/mds.27659
Chundru, V. K., Marioni, R. E., Prendergast, J. G. D., Vallerga, C. L., Lin, T., Beveridge, A. J., SGPD Consortium,... Visscher, P. M., McRae, A. F. (2019). Examining the impact of imputation errors on fine-mapping using DNA methylation QTL as a model trait. Genetics.
10.1534/genetics.118.301861
Hoogland, J., Boel, J. A., de Bie, R. M. A., Schmand, B. A., Geskus, R. B., Dalrymple-Alford, J. C., … on behalf of the MDS Study Group “Validation of Mild Cognitive Impairment in Parkinson Disease”. (2019). Risk of Parkinson’s disease dementia related to level I MDS PD-MCI. Movement Disorders.
10.1002/mds.27617
Melzer, T. R., Stark, M. R., Keenan, R. J., Myall, D. J., MacAskill, M. R., Pitcher, T. L., Livingston, L., Grenfell, S., Horne, K., Young, B., Pascoe, M., Almuqbel, M. A., Wang, J., Marsh, S., Miller, D. H., Dalrymple-Alford, J. C., Anderson, T. J. (2019). Beta amyloid deposition is not associated with cognitive impairment in Parkinson’s disease. Frontiers in Neurology,
10, .
10.3389/fneur.2019.00391
Nalls, M. A., Blauwendraat, C., Vallerga, C. L., Heilbron, K., Bandres-Ciga, S., Chang, D., and the System Genomics of Parkinson’s Disease Consortium and the International Parkinson’s Disease Genomics Consortium (2019). Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies. The Lancet Neurology,
18(12), .
10.1016/S1474-4422(19)30320-5
Reynolds, R. H., Botía, J., Nalls, M. A., International Parkinson’s Disease Genomics Consortium (IPDGC), System Genomics of Parkinson’s Disease (SGPD), Hardy, J., Taliun, S. A. G., Ryten, M. (2019). Moving beyond neurons: the role of cell type-specific gene regulation in Parkinson’s disease heritability. npj Parkinson's Disease,
5, .
10.1038/s41531-019-0076-6
Watanabe, M., Okada, K. I., Hamasaki, Y., Funamoto, M., Kobayashi, Y., MacAskill, M. R., Anderson, T. J. (2019). Ocular drift reflects volitional action preparation. European Journal of Neuroscience,
50, .
10.1111/ejn.14365
Zhang, Q., Vallerga, C. L., Walker, R. M., Lin, T., Henders, A. K., Montgomery, G. W., Kennedy, M. K., Pitcher, T. L., Pearson, J., Halliday, G., Lewis, S., Anderson, T. J., ..., Visscher, P. M. (2019). Improved precision of epigenetic clock estimates across tissues and its implication for biological ageing. Genome Medicine, .
10.1186/s13073-019-0667-1
2018
Blakemore, R. L., MacAskill, M. R., Shoorangiz, R., Anderson, T. J. (2018). Stress-evoking emotional stimuli exaggerate deficits in motor function in Parkinson’s disease. Neuropsychologia,
112, .
10.1016/j.neuropsychologia.2018.03.006
Fan, D., Alamri, Y., Liu, K., MacAskill, M., Harris, P., Brimble, M., Dalrymple-Alford, J., Prickett, T., Menzies, O., Laurenson, A., Anderson, T., Guan, J. (2018). Supplementation of blackcurrant anthocyanins increased cyclic glycine-proline in the cerebrospinal fluid of Parkinson patients: potential treatment to improve insulin-like growth factor-1 function. Nutrients,
10, .
10.3390/nu10060714
Grasby, Katrina L., Jahanshad, Neda, Painter, Jodie N., ..., Melzer, Tracy R., ..., Pitcher, Toni L., ..., Anderson, Tim J., ..., Dalrymple-Alford, John C., ..., on behalf of the Enhancing NeuroImaging Genetics through Meta-Analysis Consortium - Genetics working group (2018). The genetic architecture of the human cerebral cortex. BioRxiv, .
10.1101/399402
Pascoe, M. J., Alamri, Y., Dalrymple-Alford, J. C., Anderson, T. J., MacAskill, M. R. (2018). The Symbol-Digit Modalities Test in mild cognitive impairment: evidence from Parkinson's disease patients. European Neurology,
79, .
10.1159/000485669
Pitcher, T. L., Myall, D. J., Pearson, J. F., Lacey, C. J., Dalrymple-Alford, J. C., Anderson, T. J., MacAskill, M. R. (2018). Parkinson’s disease across ethnicities: a nation-wide study in New Zealand. Movement Disorders,
33, .
10.1002/mds.27389
Snell, D. L., Martin, R., Macleod, A. D., Surgenor, L. J., Siegert, R. J., Hay-Smith, E. J. C., Melzer, T. R., Hooper, G. J., Anderson, T. J. (2018). Untangling chronic pain and post-concussion symptoms: the significance of depression. Brain Injury,
32, .
10.1080/02699052.2018.1432894
Wu, L., Liu, F. T., Ge, J. J., Zhao, J., Tang, Y. L., Yu, W. B., Yu, H., Anderson, T. J., Zuo, C. T., Chen, L., Wang, J. (2018). Clinical characteristics of cognitive impairment in patients with Parkinson's disease and its related pattern in 18F‐FDG PET imaging. Human Brain Mapping.
10.1002/hbm.24311
Zhang, Qian, Vallerga, Costanza, ..., Pitcher, Toni L., ..., Anderson, Tim J., ..., Deary, Ian, Mcrae, Allan & Visscher, Peter (2018). Improved prediction of chronological age from DNA methylation limits it as a biomarker of ageing. BioRxiv, .
10.1101/327890
2017
Al-Busaidi, I. S., Anderson, T. J., Alamri, Y. (2017). Qualitative analysis of Parkinson’s disease information on social media: the case of YouTube™. EPMA Journal,
8, .
Alamri, Y., Anderson, T., Dalrymple-Alford, J., MacAskill, M. (2017). Errors on the MoCA's animal-naming: findings from Parkinson’s disease patients. International Psychogeriatrics, .
10.1017/S1041610217000345
Hoogland, J., Boel, J. A., de Bie, R. M. A., Geskus, R. B., Schmand, B. A., Dalrymple-Alford, J. C., Marras, C., Adler, C. H., Goldman, J. G., Tröster, A. I., Burn, D. J., Litvan, I., Geurtsen, G. J., MDS Study Group “Validation of Mild Cognitive Impairment in Parkinson Disease”. (2017). Mild cognitive impairment as a risk factor for Parkinson’s disease dementia. Movement Disorders,
32, .
10.1002/mds.27002
Jones, A. J., Kuijer, R. G., Livingston, L., Myall, D., Horne, K., MacAskill, M., Pitcher, T., Barrett, P. T., Anderson, T. J., Dalrymple-Alford, J. C. (2017). Caregiver burden is increased in Parkinson’s disease with mild cognitive impairment (PD-MCI). Translational Neurodegeneration,
6(17).
10.1186/s40035-017-0085-5
Macleod, A. D., Jury, M. A., Anderson, T. J. (2017). The (palliative) care of Huntington’s disease. Progress in Palliative Care,
25, .
10.1080/09699260.2017.1337608
McAuliffe, M. J., Fletcher, A. R., Kerr, S. E., O'Beirne, G. A., Anderson, T. (2017). Effect of dysarthria type, speaking condition, and listener age on speech intelligibility. American Journal of Speech-language Pathology,
26(1), .
10.1044/2016_AJSLP-15-0182
Myall, D.J., Pitcher, T.L., Pearson, J.F., Dalrymple-Alford, J.C., Anderson, T.J., MacAskill, M.R. (2017). Parkinson's in the oldest old: Impact on estimates of future disease burden. Parkinsonism and Related Disorders,
42, .
10.1016/j.parkreldis.2017.06.018
Pearson, J. F., Alla, S., Clarke, G., Mason, D. F., Anderson, T., Richardson, A., Miller, D. H., Sabel, C. E., Abernethy, D. A., Willoughby, E. W., Taylor, B. V. (2017). Multiple sclerosis impact on employment and income in New Zealand. Acta Neurologica Scandinavica,
136, .
10.1111/ane.12714
Woodward, Z., Prickett, T. C. R., Espiner, E. A., Anderson, T. J. (2017). Central and systemic C-type natriuretic peptide are both reduced in Parkinson’s disease. Parkinsonism & Related Disorders,
43, .
10.1016/j.parkreldis.2017.06.019
2016
Alamri, Y., MacAskill, M. R., Anderson, T. J. (2016). Repeated lumbar punctures for non-clinical indications: how do patients feel? European Neurology,
76(3-4), .
10.1159/000449056
Alamri, Y., Vogel, R., MacAskill, M. R., Anderson, T. J. (2016). Plasma exosome concentration may correlate with cognitive impairment in Parkinson’s disease. Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring,
4, .
10.1016/j.dadm.2016.08.002
Almuqbel, M., Melzer, T.R., Myall, D.J., MacAskill, M.R., Pitcher, T.L., Livingston, L., Wood, K., Keenan, R.J., Dalrymple-Alford, J.C., Anderson, T.J. (2016). Metabolite ratios in the posterior cingulate cortex do not track cognitive decline in Parkinson's disease in a clinical setting. Parkinsonism & Related Disorders,
22, .
10.1016/j.parkreldis.2015.11.008
Guella, I., Evans, D. M., Szu-Tu, C., Nosova, E., Bortnick, S. F., SNCA Cognition Study Group, Goldman, J. G., Dalrymple-Alford, J., Geurtsen, G. J., Litvan, I., Ross, O. A., Middleton, L. T., Parkkinen, L., Farrer, M. J. (2016). α-synuclein genetic variability: A biomarker for dementia in Parkinson's disease. Annals of Neurology,
79, .
10.1002/ana.24664
MacAskill, M. R., Anderson, T. J. (2016). Eye movements in neurodegenerative diseases. Current Opinion in Neurology,
29, .
10.1097/WCO.0000000000000274
Mace, J. L., Porter, R. J., Dalrymple-Alford, J. C., Collins, C., Anderson, T. J. (2016). Acute tryptophan depletion and Lewy body dementias. International Psychogeriatrics, .
10.1017/S1041610216000284
Schluter, P. J., Ahuriri-Driscoll, A., Anderson, T. J., Beere, P., Brown, J., Dalrymple-Alford, J., David, T., Davidson, A., Gillon, D. A., Hirdes, J., Keeling, S., Kingham, S., Lacey, C., Menclova, A. K., Millar, N., Mor, V., Jamieson, H. A. (2016). Comprehensive clinical assessment of home-based older persons within New Zealand: an epidemiological profile of a national cross-section. Australian and New Zealand Journal of Public Health.
10.1111/1753-6405.12525
Snell, D. L., Macleod, A. D. S., Anderson, T. (2016). Post-concussion syndrome after a mild traumatic brain injury: a minefield for clinical practice. Journal of Behavioral and Brain Science,
06(06), .
10.4236/jbbs.2016.66023
Wood, K., Myall, D.J., Livingston, L., Melzer, T.R., Pitcher, T.L., MacAskill, M.R., Geurtsen, G.J., Anderson, T.J., Dalrymple-Alford, J.C. (2016). Different PD-MCI criteria and risk of dementia in Parkinson’s disease: Four year longitudinal study. npj Parkinson's Disease,
2, .
10.1038/npjparkd.2015.27
2015
Alamri, Y., Al-Busaidi, I. S., MacAskill, M.R., Anderson, T.J. (2015). Anxiety and depression in Parkinson’s disease patients in Saudi Arabia Global neurology. Journal of the Neurological Sciences,
358, .
10.1016/j.jns.2015.07.051
Alamri, Y., MacAskill, M., Anderson, T., Benamer, H. (2015). Parkinson’s disease in the Gulf Countries: An updated review. European Neurology,
74(3-4), .
10.1159/000442283
Anderson, T (2015). How Do I Examine for a Supranuclear Gaze Palsy? Movement Disorders Clinical Practice,
2 (1), .
10.1002/mdc3.12116
Luckey, A. M., Anderson, T., Silverman, M. H., Webster, G. (2015). Safety, tolerability and pharmacodynamics of a novel immunomodulator, MIS416, in patients with chronic progressive multiple sclerosis. Multiple Sclerosis - Journal Experimental, Translational and Clinical,
1, .
10.1177/ 2055217315583385
Martin, T., Weatherall, M., Anderson, T. J., MacAskill, M. R. (2015). A randomised controlled feasibility trial of a specific cueing programme for falls management in patients with Parkinson disease and freezing of gait. Journal of Neurologic Physical Therapy,
39(3), .
10.1097/npt.0000000000000093
Melzer, T.R., Myall, D.J., MacAskill, M.R., Pitcher, T.L., Livingston, L., Watts, R., Keenan, R.J., Dalrymple-Alford, J.C., Anderson, T.J. (2015). Tracking Parkinson's disease over one year with multimodal magnetic resonance imaging in a group of older patients with moderate disease. PLOS ONE,
10, .
10.1371/journal.pone.0143923
Wilcox, R., Brænne, I., Brüggemann, N., Winkler, S., Wiegers, K., Bertram, L., Anderson, T., Lohmann, K. (2015). Genome sequencing identifies a novel mutation in ATP1A3 in a family with dystonia in females only. Journal of Neurology,
262(1), .
10.1007/s00415-014-7547-9
2014
Baylor, C, McAuliffe, MJ, Hughes, LE, Yorkston, K, Anderson, TJ, Kim J, Amtmann, D (2014). A differential item functioning (DIF) analysis of the Communicative Participation Item Bank (CPIB): Comparing individuals with Parkinson's disease from the United States and New Zealand. Journal of Speech Language Hearing Research,
57, .
10.1044/1092-4388
Espiner, E. A., Dalrymple-Alford, J. C., Prickett, T. C. R., Alamri, Y. , Anderson, T.J. (2014). C-type natriuretic peptide in Parkinson's disease: reduced secretion and response to deprenyl. Journal of Neural Transmission,
121(4), .
10.1007/s00702-013-1123-9
Geurtsen, GJ, Hoogland, J, Goldman, JG, Schmand, BA, Tröster, AI, Burn, DJ, Litvan, I, on behalf of the MDS Study group on the validation of PD-MCI criteria. (2014). Parkinson’s Disease Mild Cognitive Impairment: Application and Validation of the Criteria. Journal of Parkinson’s Disease,
4, .
10.3233/JPD-130304
Le Heron, C. J., Wright, S. L., Melzer, T. R., Myall, D. J., MacAskill, M. R., Livingston, L., Keenan, R. J., Watts, R., Dalrymple-Alford, J. C. , Anderson, T.J. (2014). Comparing cerebral perfusion in Alzheimer's disease and Parkinson's disease dementia: an ASL-MRI study. Journal of Cerebral Blood Flow & Metabolism,
34, .
10.1038/jcbfm.2014.40
McAuliffe, MJ, Kerr, SE, Gibson, EMR, Anderson, TJ, LaShell, PJ (2014). Cognitive-perceptual examination of remediation approaches to hypokinetic dysarthria. Journal of Speech, Language & Hearing Research,
57, .
10.1044/2014_JSLHR-S-12-0349
Pitcher, T. L., MacAskill, M. R., Anderson, T. J. (2014). Trends in antiparkinsonian medication use in New Zealand: 1995-2011. Parkinson’s Disease,
2014(379431), .
10.1155/2014/379431
Toh, E., MacAskill, M., Dalrymple-Alford, J., Myall, D., Livingston, L., Macleod, S. , Anderson, T. (2014). Comparison of cognitive and UHDRS measures in monitoring disease progression in Huntington's disease: a 12-month longitudinal study. Translational Neurodegeneration,
3.
Wu, TY, Taylor, JM, Kilfoyle, DH, Smith, AD, McGuinness, BJ, Simpson, MP, Walker, EB, Bergin, PS, Cleland, JC, Hutchinson, DO, Anderson, NE, Snow, BJ, Anderson, TJ, Paermentier, LA, Cutfield, NJ, Chancellor, AM, Mossman, SS, Roxburgh, RH (2014). Autonomic dysfunction is a major feature of cerebellar ataxia, neuropathy, vestibular areflexia ‘CANVAS’ syndrome. Brain,
137(10), .
10.1093/brain/awu196
2013
Anderson, T. (2013). Could saccadic function be a useful marker of stroke recovery? Journal of Neurology Neurosurgery & Psychiatry,
84(3), .
10.1136/jnnp-2012-304481
Anderson, T. J., MacAskill, M. R. (2013). Eye movements in patients with neurodegenerative disorders. Nature Reviews Neurology,
9, .
10.1038/nrneurol.2012.273
Borrie, S. A., McAuliffe, M. J., Liss, J. M., O'Beirne, G. A., Anderson, T. J. (2013). The role of linguistic and indexical information in improved recognition of dysarthric speech. Journal of the Acoustical Society of America,
133, .
10.1121/1.4770239
MacAskill, M. R., Anderson, T. J. (2013). Whose name is it anyway? Varying patterns of possessive usage in eponymous neurodegenerative diseases. PeerJ,
1(e67).
10.7717/peerj.67
MacAskill, M., Myall, D. , Anderson, T. (2013). "Ocular Tremor" in Parkinson’s Disease: A Technology-dependent Artifact of Universal Head Motion? Movement Disorders,
28, .
10.1002/mds.25602
McAuliffe, M. J., Gibson, E. M., Kerr, S. E., Anderson, T. J., LaShell, P. J. (2013). Vocabulary influences older and younger listeners' processing of dysarthric speech. Journal of the Acoustical Society of America,
134, .
10.1121/1.4812764
Melzer, T. R., Watts, R., MacAskill, M. R., Pitcher, T. L., Livingston, L., Keenan, R., Dalrymple-Alford, J. C., Anderson, T. J. (2013). White matter microstructure deteriorates across cognitive stages in Parkinson disease. Neurology,
80, .
10.1212/WNL.0b013e3182929f62
Nakas, C. T., Dalrymple-Alford, J. C., Anderson, T. J., Alonzo, T.A. (2013). Generalization of Youden index for multiple-class classification problems applied to the assessment of externally validated cognition in Parkinson’s disease screening. Statistics in Medicine,
32(6), .
10.1002/sim.5592
van Stockum, S., MacAskill, M. R., Myall, D., Anderson, T. J. (2013). A perceptual discrimination task results in greater facilitation of voluntary saccades in Parkinson’s disease patients. European Journal of Neuroscience,
37(1), .
10.1111/ejn.12033
2012
Borrie, S., McAuliffe, M., Liss, J., Kirk, C., O'Beirne, G., Anderson, T. (2012). Familiarization conditions and the mechanisms that underlie improved recognition of dysarthic speech. Language & Cognitive Processes,
27, .
10.1080/01690965.2011.610596
Leow, L., Beckert, L., Anderson, T., Huckabee, M. (2012). Changes in chemosensitivity and mechanosensitivity in aging and Parkinson’s disease. Dysphagia,
27, .
MacAskill, M. R., Graham, C. F., Pitcher, T. L., Myall, D. J., Livingston, L., van Stockum, S., Dalrymple-Alford, J. C., Anderson, T. J. (2012). The influence of motor and cognitive impairment upon visually-guided saccades in Parkinson’s disease. Neuropsychologia,
50, .
10.1016/j.neuropsychologia.2012.09.025
Melzer, T. R., Watts, R., MacAskill, M. R., Pitcher, T. L., Livingston, L., Keenan, R., Dalrymple-Alford, J. C., Anderson, T. J. (2012). Grey matter atrophy in cognitively impaired Parkinson’s disease. Journal of Neurology, Neurosurgery & Psychiatry,
83(2), .
10.1186/2047-9158-1-17
Pitcher, T. L., Melzer, T. R., MacAskill, M. R., Graham, C. F., Livingston, L., Keenan, R. J., Watts, R., Dalrymple-Alford, J. C., Anderson, T. J. (2012). Reduced striatal volumes in Parkinson’s disease: a magnetic resonance imaging study. Translational Neurodegeneration,
1(1), .
10.1186/2047-9158-1-17
van Stockum, S., MacAskill, M. , Anderson, T. (2012). Impairment of voluntary saccades and facilitation of reflexive saccades do not co-occur in Parkinson’s disease. Journal of Clinical Neuroscience,
19, .
10.1016/j.jocn.2011.10.014
2011
Dalrymple-Alford, J. C., Livingston, L., MacAskill, M. R., Graham, C., Melzer, T. R., Porter, R., Watts, R., Anderson, T. J. (2011). Characterizing mild cognitive impairment in Parkinson’s disease. Movement Disorders,
26(4), .
10.1002/mds.23592
MacAskill, M. R., Koga, K., Anderson, T. J. (2011). Japanese street performer mimes violation of Hering’s Law. Neurology,
76, .
10.1212/WNL.0b013e318212a8ec
Mace, J. L., Porter, R. J., Dalrymple-Alford, J. C., Wesnes, K. A., Anderson, T.J. (2011). The effects of acute tryptophan depletion on neuropsychological function, mood and movement in the healthy elderly. Journal of Psychopharmacology,
25, .
10.1177/0269881110389094
Melzer, T. R., Watts, R., MacAskill, M. R., Pearson, J. F., Rüeger, S., Pitcher, T. L., Livingston, L., Graham, C., Keenan, R., Shankaranarayanan, A., Alsop, D. C., Dalrymple-Alford, J. C., Anderson, T. J. (2011). Arterial spin labelling reveals an abnormal cerebral perfusion pattern in Parkinson’s disease. Brain,
134(3), .
10.1093/brain/awq377
Trenkwalder, C., Kies, B., Rudzinska, M., Fine, J., Nikl, J., Honczarenko, K., Dioszeghy, P., Hill, D., Anderson, T., Myllyla, V., Kassubek, J., Steiger, M., Zucconi, M., Tolosa, E., Poewe, W., Surmann, E., Whitesides, J. (2011). Rotigotine effects on early morning motor function and sleep in Parkinson's disease: A double-blind, randomized, placebo-controlled study (RECOVER). Movement Disorders,
26, .
10.1002/mds.23441
van Stockum, S., MacAskill, M. R., Anderson, T. J. (2011). Bottom-up effects modulate saccadic latencies in well-known eye movement paradigm. Psychological Research,
75, .
10.1007/s00426-010-0305-4
van Stockum, S., MacAskill, M. R., Myall, D. , Anderson, T.J. (2011). A perceptual discrimination task abnormally facilitates reflexive saccades in Parkinson's disease. European Journal of Neuroscience,
33, .
10.1111/j.1460-9568.2011.07697.x
2010
Dalrymple-Alford, J. C., MacAskill, M. R., Nakas, C. T., Livingston, L., Graham, C., Crucian, G. P., Melzer, T. R., Kirwan, J., Keenan, R., Wells, S., Porter, R. J., Watts, R., Anderson, T.J. (2010). The MoCA: Well-suited screen for cognitive impairment in Parkinson’s disease. Neurology,
75, .
10.1212/WNL.0b013e3181fc29c9
Leow, L. P., Huckabee, M., Anderson, T., Beckert, L. (2010). The impact of dysphagia on quality of life in aging and Parkinson's disease as measured by the Swallaowing Quality of Life (SWAL-QOL) Questionnaire. Dysphagia,
25(3), .
10.1007/s00455-009-9245-9
Mace, J. L., Porter, R. J., Dalrymple-Alford, J. C., Wesnes, K. A., Anderson, T.J. (2010). The effects of acute tryptophan depletion on neuropsychological function, mood and movement in the healthy elderly. Journal of Psychopharmacology,
24(10), .
10.1177/0269881110389094
Mace, J. L., Porter, R. P., Dalrymple-Alford, J., Anderson, T.J. (2010). Effects of acute tryptophan depletion on mood in patients with Parkinson's disease and the healthy elderly. Journal of Psychopharmacology,
24, .
10.1177/0269881109105721
Norrie, J., Heitger, M., Leathem, J., Anderson, T., Jones, R., Flett, R. (2010). Mild traumatic brain injury and fatigue: A prospective longitudinal study. Brain Injury,
24, .
10.3109/02699052.2010.531687
Wu, C. C., Fairhall, S. L., McNair, N. A., Hamm, J. P., Kirk, I. J., Cunnington, R., Anderson, T. J., Lim, V.K. (2010). Impaired sensorimotor integration in focal hand dystonia patients in the absence of symptoms. Journal of Neurology, Neurosurgery and Psychiatry,
81, .
10.1136/jnnp.2009.185637
2009
Heitger, M. H., Jones, R. D., Macleod, A. D., Snell, D. L., Frampton, C. M., Anderson, T.J. (2009). Impaired eye movements in post-concussion syndrome indicate suboptimal brain function beyond the influence of depression, malingering or intellectual ability. Brain,
132, .
10.1093/brain/awp181
Innes, C. R. H., Jones, R. D., Anderson, T. J., Hollobon, S. G., Dalrymple-Alford, J.C. (2009). Performance in normal subjects on a novel battery of driving-related sensory-motor and cognitive tests. Behavior Research Methods,
42(1), .
10.3758/BRM.41.2.284
Mace, J. L., Porter, R. J., Dalrymple-Alford, J. C., Wesnes, K. A., Anderson, T.J. (2009). Effects of acute tryptophan depletion on neuropsychological and motor function in Parkinson’s disease. Journal of Psychopharmacology,
00(00), .
10.1177/0269881109105721
McKinlay, A., Grace, R. C., Kaller, C. P., Dalrymple-Alford, J. C., Anderson, T. J., Fink, J., Roger, D. (2009). Assessing cognitive impairment in Parkinson's disease: A comparison of two tower tasks. Applied Neuropsychology,
16, .
10.1080/09084280903098661
2008
Anderson, T., Luxon, L., Quinn, N., Daniel, S., Marsden, C. D., Bronstein, A. (2008). Oculomotor function in multiple system atrophy: clinical and laboratory features in 30 patients. Movement Disorders,
23(7), .
10.1002/mds.21999
Lim, A., Leow, L., Huckabee, M., Frampton, C., Anderson, T. (2008). A pilot study of respiration and swallowing integration in Parkinson’s "on" and "off" levodopa. Dysphagia,
23(1), .
10.1007/s00455-007-9100-9
McKinlay, A., Grace, R. C., Dalrymple-Alford, J. C., Anderson, T., Fink, J., Roger, D. (2008). A profile of neuropsychiatric problems and their relationship to quality of life for Parkinson’s disease patients without dementia. Parkinsonism & Related Disorders,
14(1), .
10.1016/j.parkreldis.2007.05.009
McKinlay, A., Grace, R. C., Dalrymple-Alford, J. C., Anderson, T., Fink, J., Roger, D. (2008). Neuropsychiatric problems in Parkinson’s disease: Comparisons between self and significant other report. Aging and Mental Health,
12, .
10.1080/13607860802343225
McKinlay, A., Grace, R., Dalrymple-Alford, J., Anderson, T., Fink, J., Roger, D. (2008). The accuracy of the Unified Parkinson's Disease Rating Scale (UPDRS-Section 1) as a screening measure for depression. Parkinsonism and Related Disorders,
14(2), .
10.1016/j.parkreldis.2007.03.002
McKinlay, A., Kaller, C. P., Grace, R. C., Dalrymple-Alford, J. C., Anderson, T. J., Fink, J., Roger, D. (2008). Planning in Parkinson's disease: A matter of problem structure? Neuropsychologia,
46, .
10.1016/j.neuropsychologia.2007.08.018
Myall, D. J., MacAskill, M. R., Davidson, P. R., Anderson, T. J. , Jones, R.D. (2008). Design of a modular and low-latency virtual-environment platform for applications in motor adaptation research, neurological disorders, and neurorehabilitation. IEEE Transactions on Neural Systems and Rehabilitation Engineering,
16, .
r 10.1109/TNSRE.2008.922676
van Stockum, S., MacAskill, M., Anderson, T., Dalrymple-Alford, J. (2008). Don't look now or look away: Two sources of saccadic disinhibition in Parkinson's disease? Neuropsychologia,
46(13), .
10.1016/j.neuropsychologia.2008.07.002
2007
Borrie, S., McAuliffe, M. J., Tillard, G., Ormond, T., Anderson, T., Hornibrook, J. (2007). Effect of the Lee Silverman Voice Treatment (LSVT) on articulation in speakers with Parkinson's disease. New Zealand Journal of Speech-Language Therapy,
62, .
Heitger, M. H., Jones, R. D., Dalrymple-Alford, J. C., Frampton, C. M., Ardagh, M. W., Anderson, T.J. (2007). Mild head injury - a close relationship between motor function at one week post-injury and overall recovery at three and six months. Journal of the Neurological Sciences,
253, .
10.1016/j.jns.2006.11.007
Heitger, M. H., Jones, R. D., Dalrymple-Alford, J. C., Frampton, C. M., Ardagh, M. W., Anderson, T.J. (2007). Dichotomy between symptom status and quality of life during the first year after mild head injury - intellectual ability influences the perception of recovery. Journal of Rehabilitation Medicine,
39(8), .
Heitger, M., Jones, R., Frampton, C., Ardagh, M., Anderson, T. (2007). Recovery in the first year after mild head injury - divergence of symptom status and self-perceived quality of life. Journal of Rehabilitation Medicine,
39, .
10.2340/16501977-0100
Innes, C., Jones, R., Dalrymple-Alford, J., Hayes, S., Hollobon, S., Severinsen, J., Smith, G., Nicholls, A., Anderson, T. (2007). Sensory-motor and cognitive tests predict driving ability of persons with brain disorders. Journal of the Neurological Sciences,
260(1-2), .
10.1016/j.jns.2007.04.052
2006
Anderson, T., Heitger, M. , Macleod, A. (2006). Concussion and mild head injury. Practical Neurology,
6, .
10.1136/jnnp.2006.106583
Heitger, M., Jones, R., Dalrymple-Alford, J. C., Frampton, C. M., Ardagh, M. W. , Anderson, T. (2006). Motor deficits and recovery during the first year following mild closed head injury. Brain Injury,
20, .
10.1080/02699050600676354
2005
Heitger, M., MacAskill, M., Jones, R. , Anderson, T. (2005). The impact of mild closed head injury on involuntary saccadic adaptation - evidence for the preservation of implicit motor learning. Brain Injury,
19, .
10.1080/02699050410001720095
Le Heron, C. J., MacAskill, M. R. , Anderson, T.J. (2005). Memory-guided saccades in Parkinson's disease: long delays can improve performance. Experimental Brain Research,
161, .
10.1007/s00221-004-2071-2
Stott, V., Hurrell, M. A. , Anderson, T.J. (2005). Reversible posterior leunkoencephalopathy (RPL) syndrome - a misnomer reviewed. Intern Medical Journal,
35(2), .
2004
Heitger, M., Anderson, T., Jones, R., Dalrymple-Alford, J., Frampton, C. , Ardagh, M. (2004). Eye movement and visuomotor arm movement deficits following mild closed head injury. Brain,
127, .
10.1093/brain/awh066
Spieth, B., MacAskill, M. R. , Anderson, T.J. (2004). Der Einfluss von Morbus Parkinson auf die Ausfuhrung von Sakkaden [The influence of Parkinson’s disease on the execution of saccades]. Orthoptik Pleoptik,
28, .
2003
MacAskill, M. R., Jones, R. D., Anderson, T. J. (2003). Saccadic suppression of displacement: effects of illumination and background manipulation. Perception,
32(4), .
Muir, S. R., MacAskill, M. R., Herron, D., Goelz, H., Anderson, T. J., Jones, R. D. (2003). EMMA “ an eye movement measurement and analysis system. Australasian Physical and Engineering Sciences in Medicine,
26, .
2002
Heitger, M. H., Anderson, T. J., Jones, R. D. (2002). Saccadic sequences as a marker of deficits in closed head injury. Progress in Brain Research,
140, .
Irie, K., Wilson, B. A., Jones, R. D., Bones, P. J., Anderson, T. J. (2002). A laser-based eye-tracking system. Behavior Research Methods, Instruments, & Computers,
34(4), .
Jones, R. D., White, A. J., Lawson, K. H., Anderson, T. J. (2002). Visuoperceptual and visuomotor deficits in developmental stutterers: An exploratory study. Human Movement Science,
21, .
MacAskill, M. R., Anderson, T. J., Jones, R. D. (2002). Adaptive modification of saccade amplitude in Parkinson’s disease. Brain,
125(7), .
MacAskill, M. R., Anderson, T. J., Jones, R. D. (2002). Saccadic adaptation in neurological disorders. Progress in Brain Research,
140, .
2001
Mulligan, H., Anderson, T., Jones, R., Williams, M. , Donaldson, I. (2001). Dysfluency and involuntary movements: A new look at developmental stuttering. International Journal of Neuroscience,
109, .
2000
MacAskill, M. R., Anderson, T. J., Jones, R. D. (2000). Suppression of displacement in severely slowed saccades. Vision Research,
40(24), .
1999
Donaldson, I. , Anderson, T. (1999). Now you sees it; now you don't - the episodic movement disorders. New Zealand Medical Journal,
112, .
MacAskill, M. R., Muir, S. R., Anderson, T. J. (1999). Saccadic suppression and adaptation: revisiting the methodology. In W. Becker, H. Deubel, & T, Mergner (Eds). Current oculomotor research: physiological and psychological aspects., ,
New York: Plenum.
1998
Donaldson, I. , Anderson, T. (1998). Shuffling slowly forwards: recent advances in Parkinson's disease management. New Zealand Medical Journal,
111, .
Fink, J. , Anderson, T. (1998). Lower cranial nerve palsies due to carotid artery dissection. New Zealand Medical Journal,
111, .
Fink, J. N., Donaldson, I., Avery, S. , Anderson, T. (1998). Is hypokalaemic periodic paralysis more prevalent in Maori. Australian and New Zealand Journal of Medicine,
28, .
10.1111/j.1445-5994.1998.tb02090.x
1995
Anderson, T. J. (1995). Spasmodic torticollis. In A. P. Moore (Ed.), Handbook of Botulinum Toxin Treatment, ,
Blackwell Scientific Publications, Oxford.
Anderson, T. J. , Donaldson, I.M. (1995). Botulinum toxin; one man's poison is another man's potion. New Zealand Medical Journal,
108, .
1994
Anderson, T. J., Jenkins, I. H., Hawken, M., Frackowiak, R S J: Kennard, C , Brooks, D.J. (1994). Cortical control of saccades and fixation in man: a PET study. Brain,
117, .
Steiger, M. J., El Debas, T., Anderson, T., Findley, L. J. , Marsden, C.D. (1994). Double blind study of the activity and tolerability of cabergoline versus placebo in parkinsonians with motor fluctuations. Journal of Neurology,
243, .
1992
Anderson, T., Ewer, T., Gilchrist, N. , Donaldson, I.M. (1992). A trial of Sinemet CR4 in patients with Parkinson's disease. New Zealand Medical Journal,
105, .
1990
Anderson, T., Carroll, G., Avery, S., Donaldson, I. , Parkin, P. (1990). Eaton-Lambert myasthenic syndrome: two cases with typical and atypical features. New Zealand Medical Journal,
103, .
Anderson, T., Donaldson, I. M., Sheat, J. , George, P. (1990). Methylprednisolone in multiple sclerosis exacerbation: changes in CSF parameters. Australian and New Zealand Journal of Medicine,
20, .
1989
Anderson, T. , Donaldson, I. (1989). Successful medical treatment of subdural haematoma while maintained on anticoagulants. British Medical Journal,
299, .
Anderson, T. J., Donaldson, I. M. (1989). Spontaneous resolution of cervical spinal epidural haematoma. Postgraduate Medical Journal,
65, .
George, P., Sheat, J. , Anderson, T.J. (1989). Cystatin C Quantification in CSF. Clinical Chemistry,
35, .
Abstracts and Short papers
2022
Zhao, Y., van Heese, E., Laansma, M. A., Al‐Bachari, S., Anderson, T., Assogna, F., ..., Dalrymple-Alford, J., ..., Melzer, T., ..., Pitcher, T., ..., Gutman, B. A. (2022). TV‐L1 Ordinal Logistic Regression Reveals New Morphometric Patterns Related to Parkinsonian Symptom Severity: An ENIGMA‐PD study. Alzheimer's & Dementia,
18, .
10.1002/alz.067037
2020
Horne, K.-L., MacAskill, M. R., Myall, D., Livingston, L., Grenfell, S., Pascoe, M. J., Young, B., Shoorangiz, R., Melzer, T. R., Pitcher, T. L., Anderson, T. J., Dalrymple-Alford, J. C. (2020). Neuropsychiatric symptoms are associated with dementia in Parkinson’s disease but not predictive of it. MedRxiv, 2020, 09,
01, .
https://doi.org/10.1101/2020.09.01.20186312
2019
Alamri Y., Pascoe M. J., MacAskill M. R., Anderson T. J., Dalrymple-Alford J. C. (2019). Sensorimotor integration assessment by the Symbol-Digit modalities test in patients with Parkinson’s disease. Neurosciences 24, .
10.17712/nsj.2019.2.20190002
2018
Blakemore, R.L., MacAskill, M.R., Myall, D.J., Anderson, T.J. (2018). Parkinsonian tremor can be diminished by willpower. Proceedings of the International Australasian Winter Conference on Brain Research,
36, .
Horne, K. L., Myall, D. J., MacAskill, M. R., Anderson, T. J., Dalrymple-Alford, J. C. (2018). Response to “Parkinson's disease mild cognitive impairment classifications and neurobehavioral symptoms” [letter]. International Psychogeriatrics.
10.1017/S1041610218000091
2016
Horne, K, Myall, DJ, Livingston, L, Grenfell, SF, Melzer, TR, Pitcher, TL, MacAskill, MR, Anderson, TJ, Dalrymple-Alford, JC (2016). Risk of dementia in Parkinson’s disease: Towards optimal short cognitive testing. Proceedings of the 34th International Winter Conference on Brain Research, .
Melzer, TR, Keenan, RJ, Myall, DJ, Kaur, G, Livingston, L, Horne, K, Marsh, S, MacAskill, MR, Dalrymple-Alford, JC, Anderson, TJ (2016). Amyloid imaging and cognition in Parkinson’s disease: Interim report. Proceedings of the 34th International Winter Conference on Brain Research, .
Myall, DJ, Pitcher, TL, MacAskill, MR, Pearson, JF, Lacey, C, Dalrymple-Alford, J C, Anderson, T J (2016). Epidemiology of Parkinson’s in New Zealand: Sex, age, and future burden. Proceedings of the 34th International Winter Conference on Brain Research, 34,
10, .
Pitcher, TL, Myall, DJ, MacAskill, MR, Pearson, JF, Lacey, C, Dalrymple-Alford, J C, Anderson, T J (2016). Ethnic and regional differences in Parkinson’s disease in New Zealand. Proceedings of the 34th International Winter Conference on Brain Research, .
2015
Alla, S., Pearson, J. F., Clarke, G., Mason, D. F., Miller, D. H., Richardson, A., Anderson, T., Abernethy, D., Willoughby, E., Sabel, C.E., Taylor, B. V. (2015). Employment among persons with multiple sclerosis in New Zealand (Abstract). Multiple Sclerosis Journal,
23(11, Suppl.), .
10.1177/1352458515602642
Almuqbel, M, Melzer, TR, Myall, DJ, MacAskill, MR, Livingston, L, Pitcher, TL, Dalrymple-Alford, JC, Anderson, TJ (2015). Longitudinal magnetic resonance spectroscopy in Parkinson’s disease. Proceedings of the 21st Annual Meeting of the Organization for Human Brain Mapping.
Melzer, TR, Myall, DJ, MacAskill, MR, Livingston, L, Pitcher, TL, Watts, R, Keenan, RJ, Dalrymple-Alford, JC, Anderson, TJ (2015). White matter lesions contribute to future dementia in Parkinson’s disease. Proceedings of the 21st Annual Meeting of the Organization for Human Brain Mapping.
2014
Almuqbel, M., Melzer, T., Myall, D., MacAskill, M., Livingston, L., Wood, K., Pitcher, T., Dalrymple-Alford, J. , Anderson, T. (2014). Cognitive status in Parkinsons disease characterised by magnetic resonance spectroscopy. Proceedings of the International Australasian Winter Conference on Brain Research (AWCBR), Queenstown, New Zealand,
32, .
Melzer, T., Myall, D., Livingston L., , Wood, K., Pitcher, T., Keenan, R., MacAskill, M., Dalrymple-Alford, J. , Anderson, T. (2014). White matter lesions - a factor in developing dementia in patients with Parkinsons disease. Proceedings of the International Australasian Winter Conference on Brain Research (AWCBR), Queenstown, New Zealand,
32, .
Myall, D., Wood, K., Livingston, L., Pitcher, T., Melzer, T., MacAskill, M., Anderson, T. , Dalrymple-Alford, J. (2014). Individualised medicine: Predicting dementia in Parkinsons disease. Proceedings of the International Australasian Winter Conference on Brain Research (AWCBR), Queenstown, New Zealand,
32, .
Wood, K., Myall, D., Livingston, L., Melzer, T., Pitcher, T., MacAskill, M., Anderson, T. , Dalrymple-Alford, J. (2014). Comparing mild cognitive impairment criteria in Parkinsons disease: influence on dementia onset. Proceedings of the International Australasian Winter Conference on Brain Research (AWCBR), Queenstown, New Zealand,
32, .
2013
Alamri, Y., MacAskill, M., Myall, D., Dalrymple-Alford, J., & Anderson, T. (2013). Animal-naming in Parkinson's disease (Abstract). 2013 Neuroscience Meeting Planner San Diago,
CA: Society for, ,
Program No.10/N5..
Dalrymple-Alford, J. C., Livingston, L., Melzer, T. R., Wood, K., Goh, T. J., Pitcher, T. L., Graham, C. F., Keenan, R. J., MacAskill, M. R. , Anderson, T.J. (2013). Current perspectives on Parkinsons disease: Cognition to the fore. Proceedings of the 31st Australasian Winter Conference on Brain Research 2013, Queenstown, Volume 31,
Abstract 29.
Dalrymple-Alford, J., McCurrie, C., Anderson, T., Watts, R., MacAskill, M., Pitcher, T., Livingston, L., Keenan, R. , Melzer, T. (2013). Domain specific cognitive dysfunction in Parkinson’s Disease and associated pattern of grey matter atrophy. Proceedings of the Movement Disorders Society 17th International Congress - Sydney,
Abstract 572..
Grenfell, S., Melzer, T. R., Young, B., Wang, A, Livingston, L., Keenan, R. J., MacAskill, M. R., Anderson, T. J. , Dalrymple-Alford, J.C. (2013). Reduced default mode network connectivity and autobiographical memory in mild cognitive impairment. Proceedings of the 31st Australasian Winter Conference on Brain Research 2013, Queenstown,
Volume 31, .
MacAskill, M. , Anderson, T. (2013). Whose name is it anyway? The prevalence of the apostrophe in selected eponymous neurodegenerative diseases, 1960-2012, In Proceedings of the Movement Disorders Society 17th International Congress Sydney. Proceedings of the Movement Disorders Society 17th International Congress Sydney, Movement Disorders,
28 Suppl 1, .
MacAskill, M., Alamri, Y., Myall, D., Dalrymple-Alford, J., Anderson, T. (2013). Tea with milk and sugar: gaze and action coordination in a real-world task in Parkinsons disease (Abstract). Proceedings of the 17th European Conference on Eye Movement Research, Lund, Journal of Eye Movement Research,
6(3), .
Martin, T., Weatherall, M., MacAskill, M. , Anderson, T. (2013). Rhythmical auditory cueing to reduce falls and freezing of gait in Parkinsons Disease: The Cued Up! Exercise Program. Proceedings of the Movement Disorders Society 17th International Congress, Sydney, Movement Disorders,
28 Supplement 1, .
Melzer, T. R., Watts, R., MacAskill, M., Pitcher, T., Livingston, L., Keenan, R., Dalrymple-Alford, J. , Anderson, T. (2013). Serial DTI and cognitive decline in Parkinsons disease. Proceedings of the Movement Disorders Society 17th International Congress, Sydney, Movement Disorders,
28 Supplement 1, .
Pitcher, T., MacAskill, M., Anderson, T. (2013). Trends in anti-parkinsonian medication use in New Zealand: 1995-2011. In Proceedings of the Movement Disorders Society 17th International Congress, Sydney, Movement Disorders,
28 Supplement 1, .
Toh, E., MacAskill, M., Dalrymple-Alford, J., Myall, D., MacLeod, S., Livingston, L. , Anderson, T. (2013). Progression in cognitive function of Huntington patients relative to controls: a 12 months study. Proceedings of the Movement Disorders Society 17th International Congress, Sydney, Movement Disorders,
28 Supplement 1, .
Toh, E., MacAskill, M., Dalrymple-Alford, J., Myall, D., MacLeod, S., Livingston, L. , Anderson, T. (2013). Proceedings of the Movement Disorders Society 17th International Congress, Sydney, Movement Disorders,
28 Supplement 1, .
Wood, K., Livingston, L., Melzer, T. R., Pitcher, T. L., MacAskill, M. R., Anderson, T. J. , Dalrymple-Alford, J.C. (2013). Criteria for Parkinson’s disease with mild cognitive impairment associated with increased progression to dementia. Proceedings of the 31st Australasian Winter Conference on Brain Research 2013, Queenstown,
Volume 31, .
2012
Toh, E., MacAskill, M., Dalrymple-Alford, J., Myall, D., Livingston, L., MacLeod, A. , Anderson, T. (2012). Impairment of implicit prediction in rhythmic saccadic movement in symptomatic huntington patients (Abstract). Journal of Neurology, Neurosurgery, and Psychiatry,
83:Suppl 1, .
10.1136/jnnp-2012-303524.104
Toh, E., MacAskill, M., Dalrymple-Alford, J., Myall, D., Livingston, L., Ross, J., Anderson, T. (2012). The effectiveness of cognitive and reflexive saccade measures in discriminating Huntingtons disease from healthy controls (Abstract). European Journal of Neurology,
19 Suppl 1, .
10.1111/j.1468-1331.2012.03888.x
2008
Myall, D. J., MacAskill, M. R., Anderson, T. J., Jones, R. D. (2008). Submovements in visually-guided and memory-guided reaching tasks: changes in Parkinson’s disease. In Proceedings of the 30th Annual International Conference of IEEE Engineering in Medicine and Biology Society.
_2024.pdf.jpeg)
_1999.pdf.jpeg)
